Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Objective

There are variations in prognosis and therapeutic approach for renal cell carcinoma among different histological subtypes. This study aims to determine the relationship between radiologically detected peritumoral neovascularization and the histological subtypes of Renal Cell Carcinoma (RCC) and to assess whether extratumoral neovascularization characteristics detected imaging can contribute to distinguishing these subtypes alongside tumor size and T-stage.

Materials and Methods

104 renal tumors from 104 cases consisting of 31 females (29.8%) and 73 males (70.2%) who underwent abdominal CT or MRI and received a histopathological renal cell carcinoma diagnosis were included. Out of 104 cases, 45 (43.27%) cases had a preoperative CT, 52 (50%) cases had a preoperative MRI, and 7 (6.73%) cases had both preoperative CT and MR images. The cases were categorized according to the histopathologic subtypes. The presence of the radiologically visible peritumoral vascularity and its diameter was noted in order to compare with the histopathological subtypes and other morphologic or histopathological findings, including size, presence of cystic component, T score, and Fuhrman grade of the tumor.

Results

104 unilateral renal tumors (median size 5 cm; range 2-26 cm) were included in this study, of which 71 (68.3%) were clear cell, 20 (9.2%) were papillary and 13 (12.5%) were chromophobe renal cell carcinomas. Although the presence of peritumoral neovascularization was observed to a lesser degree in papillary carcinomas than clear cell and chromophobe carcinomas, there was no statistically significant difference among histological subtypes and between clear cell and non-clear cell carcinomas according to the frequency of peritumoral neovascularization ( = 0.16 and = 0.084). The presence of peritumoral neovascularization was significantly associated with tumor size for all tumors and within histological subtypes ( < 0.0001). As the diameter of the tumor increased, the presence of peritumoral neovascularization increased. T stage of tumors was significantly associated with both the presence of peritumoral neovascularization and the largest peritumoral vessel diameter ( < 0.01 and = 0.002).

Conclusion

No statistically significant association between the histological subtype of tumors and the frequency of peritumoral neovascularization was found in this study. The frequency of peritumoral neovascularization increased with the size and T stage of the tumor. Additionally, the largest peritumoral vessel diameter increased with the T stage of the tumor. There was no statistically significant relationship between peritumoral vascularity and Fuhrman grade.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056303423241118074519
2024-01-01
2025-06-25
The full text of this item is not currently available.

References

  1. JonaschE. GaoJ. RathmellW.K. Renal cell carcinoma.BMJ2014349nov10 11g479710.1136/bmj.g479725385470
    [Google Scholar]
  2. LjungbergB. AlbigesL. Abu-GhanemY. BedkeJ. CapitanioU. DabestaniS. Fernández-PelloS. GilesR.H. HofmannF. HoraM. KlatteT. KuuskT. LamT.B. MarconiL. PowlesT. TahbazR. VolpeA. BexA. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.Eur. Urol.202282439941010.1016/j.eururo.2022.03.00635346519
    [Google Scholar]
  3. RickettsC.J. De CubasA.A. FanH. SmithC.C. LangM. ReznikE. BowlbyR. GibbE.A. AkbaniR. BeroukhimR. BottaroD.P. ChoueiriT.K. GibbsR.A. GodwinA.K. HaakeS. HakimiA.A. HenskeE.P. HsiehJ.J. HoT.H. KanchiR.S. KrishnanB. KwiatkowskiD.J. LiuW. MerinoM.J. MillsG.B. MyersJ. NickersonM.L. ReuterV.E. SchmidtL.S. ShelleyC.S. ShenH. ShuchB. SignorettiS. SrinivasanR. TamboliP. ThomasG. VincentB.G. VockeC.D. WheelerD.A. YangL. KimW.Y. RobertsonA.G. SpellmanP.T. RathmellW.K. LinehanW.M. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbrotE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. Gastier-FosterJ.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. Longatto-FilhoA. ReisR.M. Scapulatempo-NetoC. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. Barnholtz-SloanJ.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van MeirE.G. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. GonzalezA.M.A. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. Stretch SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. Gimenez-RoqueploA-P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. PineroE.M.M. Quintero-AguiloM. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. Fantacone-CampbellJ.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma.Cell Rep.2018231313326.e510.1016/j.celrep.2018.03.07529617669
    [Google Scholar]
  4. BukavinaL. BensalahK. BrayF. CarloM. ChallacombeB. KaramJ.A. KassoufW. MitchellT. MontironiR. O’BrienT. PanebiancoV. SceloG. ShuchB. van PoppelH. BlosserC.D. PsutkaS.P. Epidemiology of Renal Cell Carcinoma: 2022 Update.Eur. Urol.202282552954210.1016/j.eururo.2022.08.01936100483
    [Google Scholar]
  5. LeibovichB.C. LohseC.M. CrispenP.L. BoorjianS.A. ThompsonR.H. BluteM.L. ChevilleJ.C. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.J. Urol.201018341309131610.1016/j.juro.2009.12.03520171681
    [Google Scholar]
  6. PalumboC. PecoraroA. KnipperS. RosielloG. LuzzagoS. DeukerM. TianZ. ShariatS.F. SimeoneC. BrigantiA. SaadF. BerrutiA. AntonelliA. KarakiewiczP.I. Contemporary age-adjusted incidence and mortality rates of renal cell carcinoma: Analysis according to gender, race, stage, grade, and histology.Eur. Urol. Focus20217364465210.1016/j.euf.2020.05.00332456993
    [Google Scholar]
  7. VolpeA. NovaraG. AntonelliA. BertiniR. BilliaM. CarmignaniG. CunicoS.C. LongoN. MartignoniG. MinerviniA. MironeV. SimonatoA. TerroneC. ZattoniF. FicarraV. Chromophobe renal cell carcinoma (RCC): Oncological outcomes and prognostic factors in a large multicentre series.BJU Int.20121101768310.1111/j.1464‑410X.2011.10690.x22044519
    [Google Scholar]
  8. GarjeR. ElhagD. YasinH.A. AcharyaL. VaenaD. DahmoushL. Comprehensive review of chromophobe renal cell carcinoma.Crit. Rev. Oncol. Hematol.202116010328710.1016/j.critrevonc.2021.10328733753250
    [Google Scholar]
  9. MendhirattaN. MurakiP. SiskA.E.Jr ShuchB. Papillary renal cell carcinoma: Review.Urol. Oncol.202139632733710.1016/j.urolonc.2021.04.01334034966
    [Google Scholar]
  10. PosadasE.M. LimvorasakS. SharmaS. FiglinR.A. Targeting angiogenesis in renal cell carcinoma.Expert Opin. Pharmacother.201314162221223610.1517/14656566.2013.83220223984807
    [Google Scholar]
  11. KayF.U. PedrosaI. Imaging of Solid Renal Masses.Urol. Clin. North Am.201845331133010.1016/j.ucl.2018.03.01330031457
    [Google Scholar]
  12. SchiedaN. LimR.S. McInnesM.D.F. ThomassinI. Renard-PennaR. TavolaroS. CornelisF.H. Characterization of small (<4 cm) solid renal masses by computed tomography and magnetic resonance imaging: Current evidence and further development.Diagn. Interv. Imaging2018997-844345510.1016/j.diii.2018.03.00429606371
    [Google Scholar]
  13. MugliaV.F. PrandoA. Renal cell carcinoma: Histological classification and correlation with imaging findings.Radiol. Bras.201548316617410.1590/0100‑3984.2013.192726185343
    [Google Scholar]
  14. LowG. HuangG. FuW. MolooZ. GirgisS. Review of renal cell carcinoma and its common subtypes in radiology.World J. Radiol.20168548450010.4329/wjr.v8.i5.48427247714
    [Google Scholar]
  15. PrasadS.R. HumphreyP.A. CatenaJ.R. NarraV.R. SrigleyJ.R. CortezA.D. DalrympleN.C. ChintapalliK.N. Common and uncommon histologic subtypes of renal cell carcinoma: Imaging spectrum with pathologic correlation.Radiographics20062661795180610.1148/rg.26606501017102051
    [Google Scholar]
  16. XueL.Y. LuQ. HuangB.J. LiZ. LiC.X. WenJ.X. WangW.P. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast – enhanced ultrasonography.Eur. J. Radiol.201584101849185610.1016/j.ejrad.2015.06.01726149528
    [Google Scholar]
  17. BrinkerD.A. AminM.B. de Peralta-VenturinaM. ReuterV. ChanD.Y. EpsteinJ.I. Extensively necrotic cystic renal cell carcinoma: A clinicopathologic study with comparison to other cystic and necrotic renal cancers.Am. J. Surg. Pathol.200024798899510.1097/00000478‑200007000‑0001010895821
    [Google Scholar]
  18. HondaY. GotoK. NakamuraY. TeradaH. SentaniK. YasuiW. SekinoY. HayashiT. TeishimaJ. MatsubaraA. FujiT. KaichiY. HigakiT. BabaY. IidaM. AwaiK. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.Abdom. Radiol. (N.Y.)20174271850185610.1007/s00261‑017‑1189‑128534069
    [Google Scholar]
  19. MochH. OhashiR. Chromophobe renal cell carcinoma: Current and controversial issues.Pathology202153110110810.1016/j.pathol.2020.09.01533183792
    [Google Scholar]
  20. AlaghehbandanR. PrzybycinC.G. VerkarreV. MehraR. Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.Asian J. Urol.20229111110.1016/j.ajur.2021.11.01035198391
    [Google Scholar]
  21. TsaiC.C. WuW.J. LiC.C. WangC.J. HuangC-H. WuC.C. Epithelioid angiomyolipoma of the kidney mimicking renal cell carcinoma: A clinicopathologic analysis of cases and literature review.Kaohsiung J. Med. Sci.200925313314010.1016/S1607‑551X(09)70052‑X19419918
    [Google Scholar]
  22. SheirK.Z. El-AzabM. MosbahA. El-BazM. ShaabanA.A. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography.J. Urol.2005174245145510.1097/01.ju.0000165341.08396.a916006863
    [Google Scholar]
  23. YoungJ.R. CoyH. KimH.J. DouekM. LoP. PantuckA.J. RamanS.S. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.AJR Am. J. Roentgenol.2017208481281910.2214/AJR.16.1715228125273
    [Google Scholar]
  24. Lee-FelkerS.A. FelkerE.R. TanN. MargolisD.J.A. YoungJ.R. SayreJ. RamanS.S. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.AJR Am. J. Roentgenol.20142035W516W52410.2214/AJR.14.1246025341166
    [Google Scholar]
  25. MoldovanuC.G. BocaB. LeboviciA. Tamas-SzoraA. FeierD.S. CrisanN. AndrasI. BuruianM.M. Preoperative predicting the WHO/ISUP nuclear grade of clear cell renal cell carcinoma by computed tomography-based radiomics features.J. Pers. Med.2020111810.3390/jpm1101000833374569
    [Google Scholar]
  26. ZhangJ. LefkowitzR.A. WangL. IshillN.M. MoskowitzC.S. RussoP. HricakH. Significance of peritumoral vascularity on CT in evaluation of renal cortical tumor.J. Comput. Assist. Tomogr.200731571772310.1097/rct.0b013e318031521e17895782
    [Google Scholar]
  27. TsiliA.C. GoussiaA.C. BaltogiannisD. AstrakasL. SofikitisN. Malamou-MitsiV. ArgyropoulouM.I. Perirenal fat invasion on renal cell carcinoma: Evaluation with multidetector computed tomography-multivariate analysis.J. Comput. Assist. Tomogr.201337345045710.1097/RCT.0b013e318283bc8e23674020
    [Google Scholar]
  28. ZhuH. ZhaoS. ZuoC. RenF. FDG PET/CT and CT findings of renal cell carcinoma with sarcomatoid differentiation.AJR Am. J. Roentgenol.2020215364565110.2214/AJR.19.2246732755159
    [Google Scholar]
  29. YoshidaK. HamaokaM. KobayashiS. MatsumotoJ. InoueD. YonedaN. GabataT. Renal pelvic and ureteral wall thickening in renal cell carcinoma: Prevalence, cause, and clinical significance.Jpn. J. Radiol.2019371283284010.1007/s11604‑019‑00889‑131650427
    [Google Scholar]
  30. KangC. ShinH.J. YoonH. HanJ.W. LyuC.J. LeeM.J. Differentiation between clear cell sarcoma of the kidney and wilms’ tumor with CT.Korean J. Radiol.20212271185119310.3348/kjr.2020.088233856131
    [Google Scholar]
  31. WangK. DongL. LiS. LiuY. NiuY. LiG. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.BMC Cancer202424114810.1186/s12885‑024‑11870‑138291357
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056303423241118074519
Loading
/content/journals/cmir/10.2174/0115734056303423241118074519
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): Chromophobe RCC; Clear cell RCC; CT; MRI; Papillary RCC; Peritumoral neovascularization; RCC
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test